AUGX Share Price Performance
US$2.35
0.09 (3.98%)
Price US$2.35
Share PriceUS$2.35
AUGX Community Narratives
There are no narratives available yet.
Recent AUGX News & Updates
No updates
Augmedix, Inc. Key Details
Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.48
- Gross Margin
- 48.22%
- Net Profit Margin
- -46.23%
- Debt/Equity Ratio
- 196.1%
Augmedix, Inc. Competitors
About AUGX
- Founded
- 2013
- Employees
- 1430
- CEO
- WebsiteView website
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient’s health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was formerly known as Malo Holdings Corporation and changed its name to Augmedix, Inc. in October 2020. The company was founded in 2013 and is headquartered in San Francisco, California.
U.S. Market Performance
- 7 Days: 0.2%
- 3 Months: 12.2%
- 1 Year: 19.9%
- Year to Date: 7.6%
The Consumer Staples sector gained 3.2% while the market remained flat over the last week. As for the longer term, the market has risen 20% in the past 12 months. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading